Amphion Innovations (AMP)


Latest News

Director dealing

Amphion agrees loan restructuring

Amphion Innovations has agreed terms for re-structuring the loan payments and the draw-down of an additional US $1,55...

Comment on Polarean Fund Raise

Miscellaneous medium priority announcements

Restructure of Loan and Additional Drawdown

Miscellaneous medium priority announcements

All News

05-11-15Partner Company m2m Imaging Corp. to mergeRNS
30-10-15Death of a Director - ReplacementRNS
30-10-15Amphion chairman passes awayStockMarketWire
30-10-15Death of a DirectorRNS
17-09-15Amphion CEO to present at London forum StockMarketWire
17-09-15Amphion to present in LondonRNS
16-09-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
16-09-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
16-09-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
16-09-15Directors' DealingsRNS
10-09-15Amphion's DataTern wins patent ruling StockMarketWire
10-09-15DataTern Receives Favourable RulingRNS
03-09-15FTSE rising on miners, airlines after US, Asia gainsStockMarketWire
03-09-15Amphion NAV jumps StockMarketWire
03-09-15Interim ResultsRNS
28-08-15Holding(s) in CompanyRNS
10-08-15Amphion resolutions passed at AGMStockMarketWire
07-08-15Result of AGMRNS
22-07-15FDA QIDP DesignationRNS
22-07-15Final condition of £22m placing satisfiedRNS
01-07-15Holding(s) in CompanyRNS
26-06-15Small-cap rockets: Double or quits?Interactive Investor
23-06-15Amphion partner company raises £22m StockMarketWire
23-06-15Partner Company raises £22 millionRNS
23-06-15Amphion pre-tax losses rise StockMarketWire
23-06-15Preliminary ResultsRNS
18-06-15Motif Bio's multi-billion dollar best-seller?Interactive Investor
05-06-15FTSE dips on retailers, miners as Tsipras probedStockMarketWire
05-06-15FTSE entrenches losses as VOD, retailers sourStockMarketWire
05-06-15Amphion raises £1.54m StockMarketWire
05-06-15Placing to raise £1.54 millionRNS
19-05-15Amphion appoints joint corporate broker StockMarketWire
19-05-15Appointment of brokerRNS
15-04-15Amphion partner get FDA go-ahead for iclaprim development StockMarketWire
15-04-15FDA ResultsRNS
07-04-15Amphion warrants exercised StockMarketWire
07-04-15Shares Issued for Exercised WarrantsRNS
02-04-15Amphion partner Motif floats on AIM StockMarketWire
02-04-15First Day of Dealings of Amphion Partner CompanyRNS
24-03-15Issue of SharesRNS

RSS feeds

  • Editorial news feed for LSE:AMP Editorial
  • Regulatory news feed for LSE:AMP Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account